SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-015492
Filing Date
2020-11-04
Accepted
2020-11-04 16:06:57
Documents
18
Period of Report
2020-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20201104.htm   iXBRL 8-K 42982
2 EX-99.1 exhibit-991930.htm EX-99.1 59486
8 financialguidance-timesnew.gif GRAPHIC 10250
9 logo1.gif GRAPHIC 43773
10 opextable-timesnewroman1.gif GRAPHIC 11397
  Complete submission text file 0001628280-20-015492.txt   343374

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20201104.xsd EX-101.SCH 2462
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20201104_cal.xml EX-101.CAL 747
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20201104_def.xml EX-101.DEF 1693
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20201104_lab.xml EX-101.LAB 24270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20201104_pre.xml EX-101.PRE 12683
11 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20201104_htm.xml XML 10776
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 201286701
SIC: 2836 Biological Products, (No Diagnostic Substances)